ID   L5178Y TK+/- (clone 3.7.2C)
AC   CVCL_6665
SY   L5178Y TK+/-3.7.2c; TK+/- (clone 3.7.2C)
DR   CLO; CLO_0007196
DR   ATCC; CRL-9518
DR   BCRC; 60112
DR   BCRJ; 0140
DR   CCRID; 1101MOU-PUMC000816
DR   CCRID; 3101MOUTCM33
DR   JCRB; JCRB0709.1
DR   JCRB; FDSC0053
DR   Wikidata; Q54901039
RX   PubMed=27692294;
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9518.
CC   Doubling time: ~10 hours (Note=Lot 02052008) (JCRB=JCRB0709.1).
CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Discontinued: JCRB; FDSC0053; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4235 ! L-5178-Y-S
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 16
//
RX   PubMed=27692294; DOI=10.1016/j.mrgentox.2016.08.001;
RA   Lorge E., Moore M.M., Clements J., O'Donovan M., Fellows M.D., Honma M.,
RA   Kohara A., Galloway S., Armstrong M.J., Thybaud V., Gollapudi B.,
RA   Aardema M.J., Tanir J.Y.;
RT   "Standardized cell sources and recommendations for good cell culture
RT   practices in genotoxicity testing.";
RL   Mutat. Res. 809:1-15(2016).
//